SMTL ID : 4ddr.1

Human dihydrofolate reductase complexed with NADPH and P218

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.05 Å

Oligo State

monomer

Ligands

1 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)

NDP.1: 29 residues within 4Å: Chain A: V.8, A.9, I.16, G.17, K.18, G.20, D.21, L.22, W.24, G.53, K.54, K.55, T.56, S.59, L.75, S.76, R.77, E.78, R.91, S.92, V.115, G.116, G.117, S.118, V.120, Y.121, E.123, T.146 Ligands: MMV.2 27 PLIP interactions: 27 interactions with chain A Hydrophobic interactions: A:T.56 Hydrogen bonds: A:A.9, A:I.16, A:K.18, A:G.20, A:G.20, A:G.53, A:G.53, A:K.54, A:K.55, A:T.56, A:S.59, A:S.76, A:R.77, A:E.78, A:L.93, A:G.117, A:S.118, A:E.123 Water bridges: A:K.54, A:K.54, A:K.55, A:K.55, A:S.119, A:T.146 Salt bridges: A:K.54, A:K.55

1 x MMV: 3-(2-{3-[(2,4-diamino-6-ethylpyrimidin-5-yl)oxy]propoxy}phenyl)propanoic acid(Non-covalent)

MMV.2: 15 residues within 4Å: Chain A: I.7, V.8, A.9, D.21, L.22, E.30, F.31, F.34, S.59, I.60, P.61, V.115, Y.121, T.136 Ligands: NDP.1 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.22, A:L.22, A:F.31, A:F.31 Hydrogen bonds: A:I.7, A:Y.121, A:T.136, A:T.136 Salt bridges: A:E.30

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yuthavong, Y. et al., Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proc.Natl.Acad.Sci.USA (2012)

Release Date

2012-11-14

Peptides

Dihydrofolate reductase: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Dihydrofolate reductase

Related Entries With Identical Sequence